Posts Tagged ‘ Research & Studies ’

Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007-2008

Over the last decade the percentage of Americans who took at least one prescription drug in the past month increased by 10%.


 

Study Identifies Risks for Painkiller Addiction

The mystery of why some people are more likely to become addicted to opioid painkillers has been partially unraveled by the Geisinger Health System in Pennsylvania.


 

America’s Most Medicated State? West Virginia

Open the medicine cabinet in anyone’s home, and chances are good you find at least a couple — and perhaps many — plastic prescription drug bottles.


 

More Teens May Be Getting High off Prescription Drugs

One high school student in five has taken a prescription drug without a doctor’s order, according to a nationwide survey.


 

Baby boomers still love to get high, now using prescription meds

Nearly one in 20 U.S. residents above the age of 50 regularly abuses illegal or prescription drugs, according to a report issued by the federal Substance Abuse and Mental Health Services Administration.


 

Houston area tops Texas in prescriptions for ‘heroin high’ drug cocktail

A Texas Department of Public Safety tracking system shows that Harris County doctors rank at the top of the list in writing prescriptions for three highly addictive drugs that officials say give users a “heroin high” when taken together.


 

Acupuncture may trigger natural painkillers

Acupuncture can relieve pain, but how the ancient technique works is still something of a mystery. A new study in mice pinpoints a natural painkiller that may be a clue.


 

Opioids in Management of Chronic Noncancer Pain


 

Alkermes Announces Priority Review by FDA for VIVITROL(R) for Opioid Dependence

Alkermes, Inc. today announced that the supplemental New Drug Application (sNDA) for VIVITROL(R) (naltrexone for extended-release injectable suspension) for opioid-dependence has been designated a priority review by the U.S. Food and Drug Administration (FDA).


 

For Prescription Opioid Dependence, Relapses Associated With Shorter Treatment Course

In persons dependent on prescription opioids, tapering with buprenorphine during a 9-month period, whether initially or after a period of substantial improvement, led to nearly universal relapse in the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study, presented here at the American Psychiatric Association 2010 Annual Meeting.


 

Tapentadol Sometimes Better Tolerated, But Opioids Still First Line

New post hoc data from a 1-year safety study of tapentadol extended release show that the drug is well tolerated in low back pain and osteoarthritis.


 

Survey: Teen prescription drug abuse rising

Many parents worry about their children getting hooked on street drugs, like cocaine or heroin, but there is a growing epidemic of kids addicted to prescription pills.


 

Formulating Opioids to Deter Abuse Remains a Challenge

Grinding, crushing, crisping, soaking, stirring. These are just some of the techniques drug abusers use to extract opioids from prescription medications. The question is, can opioids be formulated to deter abuse?


 

Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events

Tapentadol extended-release (ER), an investigational drug, was associated with better gastrointestinal tolerability in elderly patients with moderate-to-severe chronic pain, with fewer discontinuing the study due to treatment-emergent adverse events (TEAEs) than oxycodone controlled-release (CR), investigators concluded in a presentation during the 29th Annual Scientific Meeting of the American Pain Society.


 

Transmucosal, Oral Opioids Found to be Concordant for Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain

Determining an effective opioid dose for chronic pain in patients who become opioid tolerant can be challenging. In fact, effective dosing of a rapid-onset transmucosal opioid for breakthrough pain is not related to the around-the-clock dose, studies have shown. However, few data exist on the effective dose of the more traditional, short-acting oral opioids.


 

Expectations and the Pain Response in Chronic Pain Management

People living with a chronic pain condition notice that sometimes they are so fearful about conducting basic tasks of daily living that they become immobilized. It can also manifest with overwhelming anxiety, so much so, that they trigger a phenomenon called ‘anticipatory pain’, which amplifies their perception of pain.


 

SIUE Pain Summit Recommendations Announced Today

The advisory council of the Pharmacy Pain and Palliative Care Summit, conducted last fall by the Southern Illinois University Edwardsville School of Pharmacy, today released its 40-page list of recommendations about how to enhance pain management training for pharmacists.


 

Risk Factors for Opioid Misuse Among Pain Patients Differ by Sex

A new study published in the April issue of the Journal of Pain reveals men and women with chronic pain who misuse opioid medications — including taking these medications at a dose frequency unsanctioned by treating physicians — do so for different reasons.


 

Gender Differences Show in Risk of Narcotic Abuse

Men and women have different reasons for abusing prescription painkillers, a new study shows.
It included 662 non-cancer patients with chronic pain who took opioid painkillers, a group of narcotics that includes morphine, codeine, fentanyl and oxycodone.


 

Chronic pain affects 1 in 4 Mass. residents, poll says

One out of four adults in Massachusetts suffers from serious, persistent pain, a new survey reports, interfering with daily life and work for most of those people at least some of the time.


 

 
« Older Entries